Seelos Therapeutics Provides Clinical Update and Reports First Quarter 2023 Financial Results Psychedelics Investing
COMPASS Pathways Announces First Quarter 2023 Financial Results and Business Highlights Psychedelics Investing
Goodness Growth Holdings to Release First Quarter 2023 Results on May 15, 2023 Psychedelics Investing
CSE Bulletin: Suspensions - ADMT, ABRT, CFT, GAIA, IWIN, PKG, POLE, PRTI, RWB, CALM, RVR, VEJI Pharmaceutical Investing
MindBio Therapeutics Corp (CSE:MBIO) Lists Its Common Shares On The Canadian Securities Exchange Psychedelics Investing
COMPASS Pathways plc to announce first quarter 2023 financial results on 11 May 2023 Psychedelics Investing
Albert Labs Receives preliminary acceptance of 35 Novel Inventive Claims for Patent Protected Manufacturing Technology Pharmaceutical Investing
Lobe Sciences Advances Governance and Capital Markets Expertise with Appointment of Mr. Nick Karakochuk to the Board of Directors
